SectorBiological Technology
Established Date31/12/2014
Listing Date02/01/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees29
Fiscal Year Ends31/12
Security TypeCommon stock
Office address40 Guest Street, Boston, MA 02135
Business
IntroductionCue Biopharma, Inc., was incorporated in Delaware on December 31, 2014. The company is a clinical-stage biopharmaceutical company that designs a new class of injectable therapies to selectively directly participate in and regulate targeted, disease-associated T cells in patients. The company's vision is to translate nature's signals, or "cues," into protein therapies by generating a new class of T-cell conjugants for the selective regulation of disease-specific T-cells.
